Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06744998
NA
Hemopatch Implication After Axillary Dissection for Breast Cancer
Sponsor: European Institute of Oncology
View on ClinicalTrials.gov
Summary
Aim of this randomized study is to assess the value of a different haemostatic sealant, the Hemopatch®, in axillary lymph node dissection (ALND) to reduce the incidence of seroma and seroma-related complications.
Official title: Hemopatch Implication After Axillary Dissection for Breast Cancer: a Randomized Clinical Study
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
190
Start Date
2025-02
Completion Date
2026-03
Last Updated
2024-12-20
Healthy Volunteers
No
Conditions
Interventions
DEVICE
Hemopatch® (Baxter)
HEMOPATCH® is an absorbable collagen pad intended for sealing and hemostasis
Locations (1)
European Institute of Oncology
Milan, Italy